Claravis
- Product NDC
- 0555-1054
- 11-digit product format
- 005551054
- Labeler code
- 0555
- Product ID
- 0555-1054_a69dde5d-5585-4313-be43-02d11fec4c9f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Isotretinoin
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA076356
- Marketing category
- ANDA
- Marketing start
- 2003-05-09
- Substance
- ISOTRETINOIN
- Active strength
- 10 mg/1
- Pharmacologic classes
- Retinoid [EPC], Retinoids [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Claravis
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ISOTRETINOIN | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | EH28UP18IF |
| Rxcui | 197843, 197844, 197845, 403930, 404059, 404062, 404065, 643488 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0555-1054-56 | Claravis | 10 in 1 CARTON | CAPSULE, LIQUID FILLED | 10 | | 18 |
| 0555-1054-60 | Claravis | 10 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 10 | | 18 |
| 0555-1054-86 | Claravis | 3 in 1 CARTON | CAPSULE, LIQUID FILLED | 3 | | 18 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ISOTRETINOIN | ACTIVE INGREDIENT | EH28UP18IF | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| ISOTRETINOIN | ACTIVE MOIETY | EH28UP18IF | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| .ALPHA.-TOCOPHEROL | INACTIVE INGREDIENT | H4N855PNZ1 | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| ALUMINUM OXIDE | INACTIVE INGREDIENT | LMI26O6933 | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| AMMONIA | INACTIVE INGREDIENT | 5138Q19F1X | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| COTTONSEED OIL | INACTIVE INGREDIENT | H3E878020N | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| D&C RED NO. 7 | INACTIVE INGREDIENT | ECW0LZ41X8 | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| ETHYLENE GLYCOL MONOETHYL ETHER | INACTIVE INGREDIENT | IDK7C2HS09 | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| SOYBEAN OIL | INACTIVE INGREDIENT | 241ATL177A | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
| WHITE WAX | INACTIVE INGREDIENT | 7G1J5DA97F | CLARAVIS (ISOTRETINOIN) CAPSULE [BARR LABORATORIES, INC.] | 8 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0555-1054 | CLARAVIS (ISOTRETINOIN) CAPSULE, LIQUID FILLED [TEVA PHARMACEUTICALS USA, INC.] | 18 | Current NDC, Legacy NDC, 3 package rows | 20220908_a31fd109-d0fd-4ab9-ba98-a3d64333c18d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0555-1054-56 | 00555105456 | 10 BLISTER PACK in 1 CARTON (0555-1054-56) / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0555-1054-60) | 10 blister pack | 2003-05-09 | 0000-00-00 | No | No | Current |
| 0555-1054-60 | 00555105460 | 10 in 1 BLISTER PACK | | | | | | Historical |
| 0555-1054-86 | 00555105486 | 3 BLISTER PACK in 1 CARTON (0555-1054-86) / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0555-1054-60) | 3 blister pack | 2003-05-09 | 0000-00-00 | No | No | Current |